Cathie Wood’s ARK ETF adjusts holdings, adds Moderna and AeroVironment stock By Investing.com

Cathie Wood’s ARK ETFs have published their daily trades for Tuesday, March 26th, 2024, showcasing a series of strategic adjustments across various sectors. The most significant acquisition for the day was in the biotech sphere, with ARK’s ARKK ETF purchasing 72,800 shares of Moderna Inc (NASDAQ:), amounting to a total dollar value of $8,035,663. This move underscores ARK’s confidence in the biotech firm, known for its mRNA technology platform and COVID-19 vaccine.

Another notable transaction involved AeroVironment Inc (NASDAQ:), a company specializing in unmanned aerial vehicles. ARK’s ETFs ARKQ and ARKX collectively bought 38,036 shares, reflecting a total investment of $5,786,416. This purchase follows a smaller acquisition of AeroVironment shares the previous day, indicating a growing interest in the defense and aerospace sector.

In communications, ARK continued to increase its stake in Iridium Communications Inc (NASDAQ:) by buying a total of 143,084 shares across ARKQ and ARKX ETFs, with a dollar value of $3,667,242. This follows a purchase of 90,000 shares on the previous Monday, suggesting a bullish stance on the satellite communications company.

Diving into defense, ARK’s ETFs ARKQ and ARKX added 39,300 shares of Kratos Defense & Security (NASDAQ:), totaling $699,147. This investment aligns with ARK’s interest in companies that are integral to national security and advanced military technology.

In a significant sell-off, ARK divested 217,799 shares of Trimble Inc (NASDAQ:TRMB) from its ARKQ and ARKX ETFs, amounting to a total value of $13,743,116. This move is part of a broader trend, as ARK has been trimming its position in the company known for GPS technology and software solutions for various industries.

Other transactions included the purchase of 73,2640 shares of Recursion Pharmaceuticals (NASDAQ:RXRX) for a value of $7,714,699 and 39,422 shares of Teradyne Inc (NASDAQ:), totaling $4,293,055. Additionally, ARK sold 1,770 shares of NVIDIA Corp (NASDAQ:) through its ARKG ETF, valued at $1,681,535.

The day’s trades reflect ARK’s ongoing strategy of investing in companies with disruptive innovation potential, while adjusting holdings to optimize the performance of its ETF portfolios. Investors following ARK’s moves will likely keep a close eye on these sectors and companies as they evolve in the market.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Cathie Wood’s ARK ETFs have published their daily trades for Tuesday, March 26th, 2024, showcasing a series of strategic adjustments across various sectors. The most significant acquisition for the day was in the biotech sphere, with ARK’s ARKK ETF purchasing 72,800 shares of Moderna Inc (NASDAQ:), amounting to a total dollar value of $8,035,663. This move underscores ARK’s confidence in the biotech firm, known for its mRNA technology platform and COVID-19 vaccine.

Another notable transaction involved AeroVironment Inc (NASDAQ:), a company specializing in unmanned aerial vehicles. ARK’s ETFs ARKQ and ARKX collectively bought 38,036 shares, reflecting a total investment of $5,786,416. This purchase follows a smaller acquisition of AeroVironment shares the previous day, indicating a growing interest in the defense and aerospace sector.

In communications, ARK continued to increase its stake in Iridium Communications Inc (NASDAQ:) by buying a total of 143,084 shares across ARKQ and ARKX ETFs, with a dollar value of $3,667,242. This follows a purchase of 90,000 shares on the previous Monday, suggesting a bullish stance on the satellite communications company.

Diving into defense, ARK’s ETFs ARKQ and ARKX added 39,300 shares of Kratos Defense & Security (NASDAQ:), totaling $699,147. This investment aligns with ARK’s interest in companies that are integral to national security and advanced military technology.

In a significant sell-off, ARK divested 217,799 shares of Trimble Inc (NASDAQ:TRMB) from its ARKQ and ARKX ETFs, amounting to a total value of $13,743,116. This move is part of a broader trend, as ARK has been trimming its position in the company known for GPS technology and software solutions for various industries.

Other transactions included the purchase of 73,2640 shares of Recursion Pharmaceuticals (NASDAQ:RXRX) for a value of $7,714,699 and 39,422 shares of Teradyne Inc (NASDAQ:), totaling $4,293,055. Additionally, ARK sold 1,770 shares of NVIDIA Corp (NASDAQ:) through its ARKG ETF, valued at $1,681,535.

The day’s trades reflect ARK’s ongoing strategy of investing in companies with disruptive innovation potential, while adjusting holdings to optimize the performance of its ETF portfolios. Investors following ARK’s moves will likely keep a close eye on these sectors and companies as they evolve in the market.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.